Nestle on Track for Another Subpar Year
Organic growth remains well below the levels being achieved by other large-cap consumer staple multinationals.
Nestle (NSRGY) is bang on track to meet our full-year forecast of 1.5% reported sales growth after a tepid first quarter. We reiterate our CHF 79 fair value estimate. We believe that the pullback in the stock since the turn of the year has been justified and that shares offer only very modest upside from current levels. Although Nestle appears to be suffering from the low-growth environment more than most of its peers, the company's wide economic moat is based on its supply-chain entrenchment, rather than brand equity. Thus, while weak pricing is not entirely surprising, we are reiterating our wide moat rating.
First-quarter organic growth of 2.8% was in line with our forecast and mercifully above the 1.9% growth of fourth-quarter 2018. It remains, however, well below the roughly 4% being achieved by many other large-cap consumer staples multinationals, primarily reflecting Nestle's soft price/mix, which again deteriorated sequentially in the quarter, to just 0.2%. Volume growth of 2.6% was an improvement over the fourth quarter, but was supported by the absence of pricing. Nestle's sales data looks particularly weak when contrasted against the performance of close competitor Danone, which achieved 4.9% like-for-like growth and posted greatly superior results in the categories in which it goes head-to-head with Nestle: bottled water and infant formula.
Geographically, sales contained few surprises and were consistent with both our forecasts and commentary from other consumer staples multinationals that have reported so far this reporting season. Zone AOA, which includes Asia, was strong with 4.7% organic growth, thanks to growth in emerging markets and a strong Chinese New Year selling period. On the other hand, Europe was weak with negative pricing.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Philip Gorham does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.